ReferIndia News FDA Greenlights Leucovorin for Autism-Related Neuropsychiatric Symptoms

ReferIndia News

Need a stunning portfolio website?

ReferIndia is your one-stop solution for design, development, and deployment—fast and professional!

Create Now
News Image

FDA Greenlights Leucovorin for Autism-Related Neuropsychiatric Symptoms

Published on: Sept. 24, 2025, 1:21 a.m. | Source: Devdiscourse

The FDA has approved leucovorin, also known as folinic acid, for managing symptoms related to autism. The approval comes amid data on its efficacy for cerebral folate deficiency, associated with autism. Previously marketed as Wellcovorin, it was withdrawn not due to safety issues but business reasons.

Checkout more news
Ad Banner

Looking for the best restaurant in Malad?

Come experience unforgettable flavors at Jayraj Restobar!

Check Now
ReferIndia News contact